These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1691640)

  • 1. Identification of a human immunodeficiency virus-1 protease cleavage site within the 66,000 Dalton subunit of reverse transcriptase.
    Graves MC; Meidel MC; Pan YC; Manneberg M; Lahm HW; Grüninger-Leitch F
    Biochem Biophys Res Commun; 1990 Apr; 168(1):30-6. PubMed ID: 1691640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential processing of homodimers of reverse transcriptases from human immunodeficiency viruses type 1 and 2 is a consequence of the distinct specificities of the viral proteases.
    Fan N; Rank KB; Leone JW; Heinrikson RL; Bannow CA; Smith CW; Evans DB; Poppe SM; Tarpley WG; Rothrock DJ
    J Biol Chem; 1995 Jun; 270(22):13573-9. PubMed ID: 7539431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase.
    Partin K; Kräusslich HG; Ehrlich L; Wimmer E; Carter C
    J Virol; 1990 Aug; 64(8):3938-47. PubMed ID: 2196384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of HIV-1 proteinase by cerulenin.
    Moelling K; Schulze T; Knoop MT; Kay J; Jupp R; Nicolaou G; Pearl LH
    FEBS Lett; 1990 Feb; 261(2):373-7. PubMed ID: 1690152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of heterodimeric human immunodeficiency virus type 1 (HIV-1) reverse transcriptase produced by in vitro processing of p66 with recombinant HIV-1 protease.
    Chattopadhyay D; Evans DB; Deibel MR; Vosters AF; Eckenrode FM; Einspahr HM; Hui JO; Tomasselli AG; Zurcher-Neely HA; Heinrikson RL
    J Biol Chem; 1992 Jul; 267(20):14227-32. PubMed ID: 1378437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli.
    Strickler JE; Gorniak J; Dayton B; Meek T; Moore M; Magaard V; Malinowski J; Debouck C
    Proteins; 1989; 6(2):139-54. PubMed ID: 2695927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease.
    Tomasselli AG; Sarcich JL; Barrett LJ; Reardon IM; Howe WJ; Evans DB; Sharma SK; Heinrikson RL
    Protein Sci; 1993 Dec; 2(12):2167-76. PubMed ID: 7507754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease.
    Margolin N; Heath W; Osborne E; Lai M; Vlahos C
    Biochem Biophys Res Commun; 1990 Mar; 167(2):554-60. PubMed ID: 2182016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.
    Pichuantes S; Babé LM; Barr PJ; DeCamp DL; Craik CS
    J Biol Chem; 1990 Aug; 265(23):13890-8. PubMed ID: 2199446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
    Meek TD; Lambert DM; Dreyer GB; Carr TJ; Tomaszek TA; Moore ML; Strickler JE; Debouck C; Hyland LJ; Matthews TJ
    Nature; 1990 Jan; 343(6253):90-2. PubMed ID: 1688646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
    Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow C; Reardon IM; Howe WJ; DeCamp DL; Craik CS; Heinrikson RL
    J Biol Chem; 1990 Aug; 265(24):14675-83. PubMed ID: 2201691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus.
    Elder JH; Schnölzer M; Hasselkus-Light CS; Henson M; Lerner DA; Phillips TR; Wagaman PC; Kent SB
    J Virol; 1993 Apr; 67(4):1869-76. PubMed ID: 8383214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant.
    Moody MD; Pettit SC; Shao W; Everitt L; Loeb DD; Hutchison CA; Swanstrom R
    Virology; 1995 Mar; 207(2):475-85. PubMed ID: 7886951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity.
    Rosé JR; Babé LM; Craik CS
    J Virol; 1995 May; 69(5):2751-8. PubMed ID: 7535864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic processing of the human T-cell lymphotropic virus 1 reverse transcriptase: identification of the N-terminal cleavage site by mass spectrometry.
    Agbuya PG; Sherman NE; Moen LK
    Arch Biochem Biophys; 2001 Aug; 392(1):93-102. PubMed ID: 11469799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation.
    Sluis-Cremer N; Arion D; Abram ME; Parniak MA
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of the HIV-1 p66 reverse transcriptase/RNase H by the p9 protease in vitro generates active p15 RNase H.
    Schulze T; Nawrath M; Moelling K
    Arch Virol; 1991; 118(3-4):179-88. PubMed ID: 1712581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease.
    Pfrepper KI; Rackwitz HR; Schnölzer M; Heid H; Löchelt M; Flügel RM
    J Virol; 1998 Sep; 72(9):7648-52. PubMed ID: 9696869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.